Current developments in pediatric systemic sclerosis
β Scribed by Ivan Foeldvari
- Book ID
- 107554060
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 326 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1523-3774
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment of systemic sclerosis (scleroderma) presents a challenge to both the patient and the physician. Established approaches include long-term physiotherapy, disease-modifying agents such as D-penicillamine, and treatment of organ involvement. These efforts are often unsatisfactory since the res
Systemic sclerosis (SSc; scleroderma), is a multiorgan systemic disease. Patients develop organ dysfunction secondary to a mixture of fibrotic and vascular disease in the setting of underlying autoimmunity. Although cutaneous fibrosis is the disease hallmark, fibrosis of visceral organs (such as the